Fulcrum Therapeutics
FULC
#8444
Rank
ยฃ0.12 B
Marketcap
ยฃ2.23
Share price
-4.32%
Change (1 day)
-69.74%
Change (1 year)

Revenue for Fulcrum Therapeutics (FULC)

Revenue in 2024 (TTM): ยฃ63.22 Million

According to Fulcrum Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ61.92 Million. an increase over the revenue in the year 2023 that were of ยฃ2.2 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fulcrum Therapeutics from 2018 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ63.74 M2795.44%
2023 ยฃ2.2 M-58%
2022 ยฃ5.24 M-63.07%
2021 ยฃ14.19 M119.32%
2020 ยฃ6.47 M
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA